Skip to content

The Comparision of Short-term and Long-term Results Between Conventional Laparoscopic Surgery and NOSES in Resection for Colorectal Cancer: An International Multicenter Randomized Prospective Trial

The Comparision of Short-term and Long-term Results Between Conventional Laparoscopic Surgery and NOSES in Resection for Colorectal Cancer: An International Multicenter Randomized Prospective Trial

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900022664
Enrollment
Unknown
Registered
2019-04-21
Start date
2019-10-01
Completion date
Unknown
Last updated
2019-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal cancer

Interventions

Group A:Conventional Laparoscopic Surgery
Group B:NOSES

Sponsors

National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. The pathological diagnosis was adenocarcinoma; 2. The distance from the tumor to the dentate line is less than 15 cm; 3. Tumors' T stage was T1-T3 before operation; 4. The age of the patients ranged from 18 to 80 years; 5. Body Mass Index (BMI) = 34kg/m2; 6. ECOG score = 3.

Exclusion criteria

Exclusion criteria: 1. ASA Grading > Grade III; 2. Laparoscopic contraindications (such as severe cardiopulmonary insufficiency); 3. Those who had undergone abdominal surgery or had extensive abdominal adhesions in the past; 4. Patients with a history of malignant tumors within 5 years; 5. Patients requiring emergency surgery (such as acute intestinal obstruction); 6. Patients with stage T1 rectal cancer who meet the criteria of transanal local excision; 7. Patients with familial adenomatous polyposis, Lynch syndrome-related rectal cancer and inflammatory bowel disease in active. 8. Patients with Preventive fistula ; 9. Patients with neoadjuvant therapy. 10. Tumors invade adjacent tissues or organs; 11. With distant organ metastasis.

Design outcomes

Primary

MeasureTime frame
Early morbidity rate;Local recurrence rate;

Secondary

MeasureTime frame
Conversion rate;Peritoneal bacterial contamination;Postoperative recovery and pain score;Functional and quality of life assessments;disease-free survival rate;overall survival rate;

Countries

Turkey

Contacts

Public ContactXishan Wang

National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

wxshan1208@126.com+86 13552367779

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026